CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-11-12 | Troendle August J. Director | Conversion · Series A Preferred Stock | −319,935 | 0 | ||
| 2014-11-12 | Troendle August J. Director | Conversion · Series B Preferred Stock | −1,556,055 | 0 | ||
| 2014-11-12 | Troendle August J. Director | Conversion · Series C Preferred Stock | −266,502 | 0 | ||
| 2014-11-12 | Troendle August J. Director | Conversion · Series B Preferred Stock | −358,428 | 0 | ||
| 2014-11-12 | FINCK BARBARA K Chief Medical Officer | Conversion | +21,505 | 21,505 | ||
| 2014-11-12 | FINCK BARBARA K Chief Medical Officer | Conversion | +5,286 | 26,791 | ||
| 2014-11-12 | FINCK BARBARA K Chief Medical Officer | Conversion · Series B Preferred Stock | −21,505 | 0 | ||
| 2014-11-12 | FINCK BARBARA K Chief Medical Officer | Conversion · Series C Preferred Stock | −5,286 | 0 | ||
| 2014-11-12 | Herman Alan C. Chief Scientific Officer | Option exercise | +239,952 | $1.67 | $400K | 239,952 |
| 2014-11-12 | Herman Alan C. Chief Scientific Officer | Other disposition | −26,756 | 213,196 | ||
| 2014-11-12 | Herman Alan C. Chief Scientific Officer | Conversion | +1,503 | 214,699 | ||
| 2014-11-12 | Herman Alan C. Chief Scientific Officer | Conversion | +39,991 | 294,940 | ||
| 2014-11-12 | Herman Alan C. Chief Scientific Officer | Conversion | +5,224 | 300,164 | ||
| 2014-11-12 | Herman Alan C. Chief Scientific Officer | Option exercise · Warrant to Purchase Common Stock | −239,952 | 0 | ||
| 2014-11-12 | Herman Alan C. Chief Scientific Officer | Option exercise · Warrant to Purchase Series B Preferred Stock | −1,505 | 0 | ||
| 2014-11-12 | Herman Alan C. Chief Scientific Officer | Option exercise · Series B Preferred Stock | +1,505 | $0.02 | $25 | 1,505 |
| 2014-11-12 | Herman Alan C. Chief Scientific Officer | Other disposition · Series B Preferred Stock | −2 | 1,503 | ||
| 2014-11-12 | Herman Alan C. Chief Scientific Officer | Conversion · Series B Preferred Stock | −1,503 | 0 | ||
| 2014-11-12 | Herman Alan C. Chief Scientific Officer | Conversion · Series A Preferred Stock | −39,991 | 0 | ||
| 2014-11-12 | Herman Alan C. Chief Scientific Officer | Conversion · Series B Preferred Stock | −5,224 | 0 |
Page 38 of 39 · 768 trades